EUVIMEDEUVIMED entdecken
Crossref

Deferoxamine prevents BBB disruption, neuroinflammation and apoptotic changes in early hours of ischemic reperfusion injury

Rajesh Ugale, Sneha Vatte, Punit Girdhar, Dinesh Anandani

Neurochemistry International · 2025

DOI: 10.1016/j.neuint.2025.106009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2025. Verfasst von Rajesh Ugale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India, 440033. Electronic address: ugale.…. Hauptthemen laut MEDLINE: Deferoxamine, Blood-Brain Barrier, Apoptosis, Reperfusion Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Iron contributes to brain damage in ischemia/reperfusion injury (I/R). Deferoxamine (DFX), an iron chelator, offers neuroprotective action in I/R animal models. However, its underlying mechanism is under investigation. This study aims to investigate effect of DFX on I/R damage led by BBB disruption, neuroinflammation, and apoptosis. METHODS: In adult male Wistar rats, cerebral ischemia was induced by middle cerebral artery occlusion (MCAO). Rats were treated with vehicle or DFX at 100, 200, and 300 mg/kg doses intraperitoneally (i.p.) at time intervals 1, 2, and 3 h of I/R injury. The neuroprotective effect of DFX was observed using histological staining and behavioural assessment after 24 h of I/R injury. Blood-brain barrier (BBB) integrity was evaluated by Evans blue staining & MMP9 expression. Anti-inflammatory effect of DFX was observed using immunohistochemical analysis whereas, anti-apoptotic effects via mRNA expressions of CREB, caspase-3, BDNF and Bcl-2. RESULTS: DFX (300 mg/kg) at 1 h of I/R injury ameliorates cerebral infarction, neurological deficits, and beam walk score. Histologically, Hoechst, hematoxylin and eosin (H & E), and cresyl violet stainings showed reduced neuronal death in DFX treated rats. It mitigates BBB disruption as observed with Evans blue staining. Additionally, DFX reduced MMP-9 expression indicative of reduced BBB disruption and improved inflammatory changes (CD86 and CD206). Besides, it inhibits mRNA expression of cleaved caspase-3 and improved expression of BDNF and Bcl-2. CONCLUSIONS: Our findings, demonstrate that DFX prevents I/R brain damage in early hour (1 h) of I/R injury by reducing BBB disruption, inflammation, and apoptosis. DFX may exhibit potential to act as adjuvant in management of acute ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeferoxamineBlood-Brain BarrierApoptosisReperfusion InjuryNeuroinflammatory DiseasesAnimalsMaleRats, WistarRatsNeuroprotective AgentsInfarction, Middle Cerebral ArteryBrain Ischemia

Stichwörter der Autor:innen

ApoptosisDeferoxamineIschemia reperfusion injuryMCAONeuroinflammation

Substanzen

DeferoxamineNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India, 440033. Electronic address: ugale.rajesh@gmail.com.
  • Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India, 440033.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Ugale, R., Vatte, S., Girdhar, P., & Anandani, D. (2025). Deferoxamine prevents BBB disruption, neuroinflammation and apoptotic changes in early hours of ischemic reperfusion injury. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.106009

Vancouver

Ugale R, Vatte S, Girdhar P, Anandani D. Deferoxamine prevents BBB disruption, neuroinflammation and apoptotic changes in early hours of ischemic reperfusion injury. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.106009

BibTeX
@article{Ugale2025,
  author = {Ugale, Rajesh and Vatte, Sneha and Girdhar, Punit and Anandani, Dinesh},
  title = {Deferoxamine prevents BBB disruption, neuroinflammation and apoptotic changes in early hours of ischemic reperfusion injury},
  journal = {Neurochemistry International},
  year = {2025},
  doi = {10.1016/j.neuint.2025.106009}
}
Kostenlos starten →